Veterinary medicines European public assessment report (EPAR): Prolevare, oclacitinib maleate, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prolevare, oclacitinib maleate, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prolevare, oclacitinib maleate, Status: Authorised
Veterinary medicines European public assessment report (EPAR): CircoMax, Porcine circovirus vaccine (inactivated recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Brucellin Aquilon, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Vectormune ND, Newcastle disease and Marek’s disease vaccine (live recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): AdTab (previously Lotilaner Elanco), lotilaner, Status: Authorised
Safety of COVID-19 vaccines
Committee for Advanced Therapies (CAT): Work Plan 2024
Paediatric Formulation Operational Expert Group
Paediatric Formulation Operational Expert Group
Herbal medicinal product: Echinaceae purpureae herbaArray, C: ongoing call for scientific data